Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) PT at $65.60

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) have received an average recommendation of "Moderate Buy" from the nine research firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $56.83.

Several research firms have issued reports on ASTH. Bank of America reduced their price objective on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a report on Tuesday. Stifel Nicolaus reduced their price objective on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a report on Thursday, February 20th. Macquarie raised Astrana Health to a "hold" rating in a report on Monday, December 16th. Robert W. Baird reduced their price objective on Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a report on Monday. Finally, Truist Financial cut their price target on Astrana Health from $59.00 to $50.00 and set a "buy" rating on the stock in a research note on Monday, January 13th.

Institutional Trading of Astrana Health

Large investors have recently made changes to their positions in the company. Handelsbanken Fonder AB increased its position in shares of Astrana Health by 4.7% in the 4th quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company's stock valued at $281,000 after buying an additional 400 shares in the last quarter. Quarry LP increased its position in shares of Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after buying an additional 471 shares in the last quarter. Nisa Investment Advisors LLC bought a new stake in shares of Astrana Health in the 3rd quarter valued at $35,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Astrana Health by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock valued at $773,000 after buying an additional 915 shares in the last quarter. Finally, Swiss National Bank increased its position in shares of Astrana Health by 1.1% in the 4th quarter. Swiss National Bank now owns 88,444 shares of the company's stock valued at $2,789,000 after buying an additional 1,000 shares in the last quarter. Institutional investors own 52.77% of the company's stock.

Remove Ads

Astrana Health Price Performance

Shares of ASTH traded up $0.41 on Friday, hitting $27.19. The company's stock had a trading volume of 327,310 shares, compared to its average volume of 244,310. The company has a market capitalization of $1.53 billion, a PE ratio of 20.92, a PEG ratio of 1.37 and a beta of 1.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. Astrana Health has a fifty-two week low of $23.12 and a fifty-two week high of $63.20. The company has a 50 day moving average price of $34.57 and a 200 day moving average price of $44.16.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.22 by ($0.37). Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The business had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million. On average, research analysts anticipate that Astrana Health will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.